Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the dry weight of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. حسب Yin Jie (21464235)

Metabolic and molecular effects of high-fat diet (HFD). حسب Ping-yu Cai (12389929)

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on ion contents of HHZ and XLY900 at days 10 under saline conditions. حسب Yin Jie (21464235)

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the growth parameters of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. حسب Yin Jie (21464235)

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on photosynthetic gas exchange parameters of HHZ and XLY900 at days 10 under saline conditions. حسب Yin Jie (21464235)

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on antioxidant system of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. حسب Yin Jie (21464235)

CaSki cells functionally express VDR and RXR. حسب Euclides Avila (41023)

Calcitriol inhibits CaSki cell migration and suppresses MMP7 and MMP13 gene expression. حسب Euclides Avila (41023)

Validation of gene expression changes induced by calcitriol in CaSki cells. حسب Euclides Avila (41023)

miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE^-/- mice. حسب Ping-yu Cai (12389929)

Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages. حسب Ping-yu Cai (12389929)

Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development. حسب Ping-yu Cai (12389929)

RICTOR silencing inhibits cell proliferation via UGCG regulation. حسب Mohammad Nafees Ansari (22232505)

"…(<b>C</b>) Cell proliferation studies show a decrease in the proliferation of MCF-7_RICTOR^SH cells (mean ± SEM, <i>n</i> = 4) compared to MCF-7_SCRAM^SH cells. …"

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

"…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …"

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). حسب Ping-yu Cai (12389929)

S1 File - حسب Ahmed Akib Jawad Karim (20427740)

"…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …"

Confusion matrix for ClinicalBERT model. حسب Ahmed Akib Jawad Karim (20427740)

"…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …"

Confusion matrix for LastBERT model. حسب Ahmed Akib Jawad Karim (20427740)

"…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …"

Student model architecture. حسب Ahmed Akib Jawad Karim (20427740)

"…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …"

Configuration of the LastBERT model. حسب Ahmed Akib Jawad Karim (20427740)

"…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …"